These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38178962)

  • 1. Copper and cuproptosis: new therapeutic approaches for Alzheimer's disease.
    Li X; Chen X; Gao X
    Front Aging Neurosci; 2023; 15():1300405. PubMed ID: 38178962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
    Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
    Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer's Disease.
    Huang X
    Cells; 2023 May; 12(10):. PubMed ID: 37408203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic models and predictive drugs associated with cuproptosis hub genes in Alzheimer's disease.
    Zhang E; Dai F; Chen T; Liu S; Xiao C; Shen X
    Front Neurol; 2022; 13():1064639. PubMed ID: 36776574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
    Springer C; Humayun D; Skouta R
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD.
    Zhang Y; Wang M; Chang W
    Front Pharmacol; 2022; 13():983623. PubMed ID: 36188557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases.
    Yang Z; Feng R; Zhao H
    Apoptosis; 2024 Jul; ():. PubMed ID: 39014119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
    Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
    Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.